0OR2 Stock Overview
Engages in the management and operation of health establishments. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
LNA Santé SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €23.30 |
| 52 Week High | €27.80 |
| 52 Week Low | €18.16 |
| Beta | 0.77 |
| 1 Month Change | -1.69% |
| 3 Month Change | 0.87% |
| 1 Year Change | 18.76% |
| 3 Year Change | -53.78% |
| 5 Year Change | -52.64% |
| Change since IPO | 37.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0OR2 | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -2.1% | -2.1% | -2.6% |
| 1Y | 18.8% | -26.1% | 2.4% |
Return vs Industry: 0OR2 exceeded the UK Healthcare industry which returned -26.1% over the past year.
Return vs Market: 0OR2 exceeded the UK Market which returned 2.4% over the past year.
Price Volatility
| 0OR2 volatility | |
|---|---|
| 0OR2 Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0OR2 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0OR2's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 7,835 | Willy Siret | www.lna-sante.com |
LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, surgery, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is based in Vertou, France.
LNA Santé SA Fundamentals Summary
| 0OR2 fundamental statistics | |
|---|---|
| Market cap | €238.25m |
| Earnings (TTM) | €23.84m |
| Revenue (TTM) | €762.03m |
10.0x
P/E Ratio0.3x
P/S RatioIs 0OR2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0OR2 income statement (TTM) | |
|---|---|
| Revenue | €762.03m |
| Cost of Revenue | €513.70m |
| Gross Profit | €248.34m |
| Other Expenses | €224.50m |
| Earnings | €23.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.33 |
| Gross Margin | 32.59% |
| Net Profit Margin | 3.13% |
| Debt/Equity Ratio | 134.3% |
How did 0OR2 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield26%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:20 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LNA Santé SA is covered by 18 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Beatrice Allen | Berenberg |
| Fraser Donlon | Berenberg |
| Stephane Sumar | BNP Paribas Exane |